The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

December 2020

Volume 16 Number 11

An EAPCI consensus document on patient-oriented management of myocardial revascularisation failure; the retrograde vs antegrade approach from the PROGRESS-CTO Registry; the PIONEER trial studying the BuMA Supreme SES. A mini focus on BRS, with: a sub-analysis of the AIDA trial studying BRS and the impact of the complexity of CAD stratified by the SYNTAX score; magnesium-based BRS in the MAGSTEMI trial; BRS implantation as a putative way to lower the incidence of neoatherosclerosis; BRS design and arterial haemodynamics; five-year clinical outcomes from the ABSORB II trial. Effectiveness of a new generation of LAA closure occluders; embolic protection devices for carotid stenting, and more…

Highlights from this issue

The MAGSTEMI-OCT study
The MAGSTEMI-OCT study
Gomez-Lara J, Ortega-Paz L, Brugaletta S, Cuesta J, Romani S, Serra A, Salinas P, Garcia del Blanco B, Goicolea J, Hernandez-Antolín R, Antuña P, Romaguera R, Regueiro A, Rivero F, Cequier A, Alfonso F, Gomez-Hospital J, Sabaté M
December 4, 2020
DOI: 10.4244/EIJ-D-20-00198

Coronary interventions - Mini focus on bioresorbable scaffolds